医疗机构中乙型肝炎病毒、丙型肝炎病毒、人类免疫缺陷病毒（1+2型）核酸检测策略专家共识

2020-12-20 中国医师协会输血科医师分会临床输血与检验.2020.22(6):561-564.

结合采供血机构及临床检测现状，以及安全输血感染性疾病检测策略多中心研究的成果，全国各地临床输血与检验专家共同编写了《医疗机构中乙型肝炎病毒、丙型肝炎病毒、人类免疫缺陷病毒（1+2型）核酸检测策略专

中文标题：

发布机构：

中国医师协会输血科医师分会

发布日期：

2020-12-20

简要介绍：

结合采供血机构及临床检测现状，以及安全输血感染性疾病检测策略多中心研究的成果，全国各地临床输血与检验专家共同编写了《医疗机构中乙型肝炎病毒、丙型肝炎病毒、人类免疫缺陷病毒（1+2型）核酸检测策略专家共识》，建议医疗机构开展HBV、HCV、HIV（1+2）核酸检测，其意义在于：①降低院内交叉感染；②降低医护人员的职业暴露风险；③发现HBV、HCV、HIV感染者，提高重大感染性疾病诊治水平；④减少医患纠纷。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=534a71c0020310ed, title=医疗机构中乙型肝炎病毒、丙型肝炎病毒、人类免疫缺陷病毒（1+2型）核酸检测策略专家共识, enTitle=, guiderFrom=临床输血与检验.2020.22(6):561-564., authorId=0, author=, summary=结合采供血机构及临床检测现状，以及安全输血感染性疾病检测策略多中心研究的成果，全国各地临床输血与检验专家共同编写了《医疗机构中乙型肝炎病毒、丙型肝炎病毒、人类免疫缺陷病毒（1+2型）核酸检测策略专, cover=https://img.medsci.cn/20201227/1609077799467_2020535.jpg, journalId=0, articlesId=null, associationId=1889, associationName= 中国医师协会输血科医师分会, associationIntro=中国医师协会输血科医师分会, copyright=0, guiderPublishedTime=Sun Dec 20 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>结合采供血机构及临床检测现状，以及安全输血感染性疾病检测策略多中心研究的成果，全国各地临床输血与检验专家共同编写了《医疗机构中乙型肝炎病毒、丙型肝炎病毒、人类免疫缺陷病毒（1+2型）核酸检测策略专家共识》，建议医疗机构开展HBV、HCV、HIV（1+2）核酸检测，其意义在于：①降低院内交叉感染；②降低医护人员的职业暴露风险；③发现HBV、HCV、HIV感染者，提高重大感染性疾病诊治水平；④减少医患纠纷。</p> </div> </div> </div> <div class="box_info" style="color: #373737;"> </div>, tagList=[TagDto(tagId=5237, tagName=乙型肝炎病毒)], categoryList=[CategoryDto(categoryId=69, categoryName=检验与病理, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=5237, guiderKeyword=乙型肝炎病毒, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2994, appHits=142, showAppHits=0, pcHits=582, showPcHits=2852, likes=2, shares=8, comments=6, approvalStatus=1, publishedTime=Sun Dec 27 22:03:53 CST 2020, publishedTimeString=2020-12-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Dec 27 22:03:40 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 21:25:44 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=医疗机构中乙型肝炎病毒_丙型肝炎_省略__1_2型_核酸检测策略专家共识_桂嵘.pdf)])

医疗机构中乙型肝炎病毒_丙型肝炎_省略__1_2型_核酸检测策略专家共识_桂嵘.pdf

下载请点击：

评论区 (5)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=919595, encodeId=04cb919595d8, content=真好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210122/c9434a0dee664c49acf84688f177697a/596598e65bcb4310a88ff4926fbea483.jpg, createdBy=dc763459754, createdName=浩浩0312, createdTime=Mon Jan 25 02:10:43 CST 2021, time=2021-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911646, encodeId=8f2d911646d9, content=很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b065448113, createdName=GLL, createdTime=Mon Dec 28 17:06:21 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911476, encodeId=34d89114e645, content=优秀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=724a5448132, createdName=ms1000000296200028, createdTime=Sun Dec 27 23:06:50 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911474, encodeId=851d9114e414, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99801968283, createdName=lucaquin, createdTime=Sun Dec 27 22:55:04 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911470, encodeId=5c369114e0d8, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Dec 27 22:47:39 CST 2020, time=2020-12-27, status=1, ipAttribution=)]
2021-01-25 浩浩0312

真好

83 0
[GetPortalCommentsPageByObjectIdResponse(id=919595, encodeId=04cb919595d8, content=真好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210122/c9434a0dee664c49acf84688f177697a/596598e65bcb4310a88ff4926fbea483.jpg, createdBy=dc763459754, createdName=浩浩0312, createdTime=Mon Jan 25 02:10:43 CST 2021, time=2021-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911646, encodeId=8f2d911646d9, content=很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b065448113, createdName=GLL, createdTime=Mon Dec 28 17:06:21 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911476, encodeId=34d89114e645, content=优秀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=724a5448132, createdName=ms1000000296200028, createdTime=Sun Dec 27 23:06:50 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911474, encodeId=851d9114e414, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99801968283, createdName=lucaquin, createdTime=Sun Dec 27 22:55:04 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911470, encodeId=5c369114e0d8, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Dec 27 22:47:39 CST 2020, time=2020-12-27, status=1, ipAttribution=)]
2020-12-28 GLL

很棒

90 0
[GetPortalCommentsPageByObjectIdResponse(id=919595, encodeId=04cb919595d8, content=真好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210122/c9434a0dee664c49acf84688f177697a/596598e65bcb4310a88ff4926fbea483.jpg, createdBy=dc763459754, createdName=浩浩0312, createdTime=Mon Jan 25 02:10:43 CST 2021, time=2021-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911646, encodeId=8f2d911646d9, content=很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b065448113, createdName=GLL, createdTime=Mon Dec 28 17:06:21 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911476, encodeId=34d89114e645, content=优秀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=724a5448132, createdName=ms1000000296200028, createdTime=Sun Dec 27 23:06:50 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911474, encodeId=851d9114e414, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99801968283, createdName=lucaquin, createdTime=Sun Dec 27 22:55:04 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911470, encodeId=5c369114e0d8, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Dec 27 22:47:39 CST 2020, time=2020-12-27, status=1, ipAttribution=)]
2020-12-27 ms1000000296200028

优秀

95 0
[GetPortalCommentsPageByObjectIdResponse(id=919595, encodeId=04cb919595d8, content=真好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210122/c9434a0dee664c49acf84688f177697a/596598e65bcb4310a88ff4926fbea483.jpg, createdBy=dc763459754, createdName=浩浩0312, createdTime=Mon Jan 25 02:10:43 CST 2021, time=2021-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911646, encodeId=8f2d911646d9, content=很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b065448113, createdName=GLL, createdTime=Mon Dec 28 17:06:21 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911476, encodeId=34d89114e645, content=优秀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=724a5448132, createdName=ms1000000296200028, createdTime=Sun Dec 27 23:06:50 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911474, encodeId=851d9114e414, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99801968283, createdName=lucaquin, createdTime=Sun Dec 27 22:55:04 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911470, encodeId=5c369114e0d8, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Dec 27 22:47:39 CST 2020, time=2020-12-27, status=1, ipAttribution=)]
2020-12-27 lucaquin

学习了

87 0
[GetPortalCommentsPageByObjectIdResponse(id=919595, encodeId=04cb919595d8, content=真好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210122/c9434a0dee664c49acf84688f177697a/596598e65bcb4310a88ff4926fbea483.jpg, createdBy=dc763459754, createdName=浩浩0312, createdTime=Mon Jan 25 02:10:43 CST 2021, time=2021-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911646, encodeId=8f2d911646d9, content=很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b065448113, createdName=GLL, createdTime=Mon Dec 28 17:06:21 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911476, encodeId=34d89114e645, content=优秀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=724a5448132, createdName=ms1000000296200028, createdTime=Sun Dec 27 23:06:50 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911474, encodeId=851d9114e414, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99801968283, createdName=lucaquin, createdTime=Sun Dec 27 22:55:04 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911470, encodeId=5c369114e0d8, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Dec 27 22:47:39 CST 2020, time=2020-12-27, status=1, ipAttribution=)]
2020-12-27 1209e435m98(暂无昵称)

学习了，谢谢分享

85 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

检验与病理指南

医疗机构中乙型肝炎病毒、丙型肝炎病毒、人类免疫缺陷病毒（1+2型）核酸检测策略专家共识

相关指南

拓展阅读

科室

工具

服务